Skip to contentC
Chemed Corp
C
CHEChemed Corp Q1 2019 · 10-Q
Revenue$462.03M$462.03M+5.2% vs Q1 2018 Net Income$44.67M$44.67M−0.7% vs Q1 2018 EPS Diluted$2.70$2.70+1.5% vs Q1 2018 Operating Income$49,472,000−12.3% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Chemed Corp · CIK 19584 · Engraved from SEC EDGAR
Free Cash Flowderived$59,719,000+13.7% Margins · derivedOperating margin10.7%−2.1 pt vs Q1 2018
Net margin9.7%−0.6 pt vs Q1 2018
ended Mar 31, 2019 · filed May 2, 2019 · 32 d after period end